Cargando…

Characterization of impurities in cefpodoxime proxetil using LC–MS(n)

Reversed-phase liquid chromatography coupled with electrospray ionization tandem mass spectrometry (ESI-MS/MS) was used to characterize impurities in cefpodoxime proxetil, an ester-modified prodrug. Based on the mechanisms by which cephalosporins are degraded, stress tests were designed and performe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jin, Zhang, Dousheng, Hu, Changqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629086/ https://www.ncbi.nlm.nih.gov/pubmed/26579402 http://dx.doi.org/10.1016/j.apsb.2014.06.007

Ejemplares similares

Formulation and in vitro characterization of cefpodoxime proxetil gastroretentive microballoons
por: Sharma, AK., et al.
Publicado: (2011)

Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs
por: Gao, Yan-Yan, et al.
Publicado: (2022)

Development and validation of spectrophotometric method of cefpodoxime proxetil using hydrotropic solubilizing agents
por: Asnani, Geet, et al.
Publicado: (2012)

Simultaneous RP-HPLC Estimation of Cefpodoxime Proxetil and Clavulanic Acid in Tablets
por: Malathi, S., et al.
Publicado: (2009)

Development of HPTLC method for determination of cefpodoxime proxetil and ambroxol hydrochloride in human plasma by liquid–liquid extraction
por: Rote, Ambadas R., et al.
Publicado: (2011)

Development and Validation of RP-HPLC Method for Simultaneous Estimation of Cefpodoxime Proxetil and Dicloxacillin Sodium in Tablets
por: Acharya, D. R., et al.
Publicado: (2013)

Validated stability-indicating high-performance thin-layer chromatographic method for estimation of cefpodoxime proxetil in bulk and in pharmaceutical formulation according to International conference on harmonization guidelines
por: Jain, Pritam, et al.
Publicado: (2012)

LC, MS(n) and LC–MS/MS studies for the characterization of degradation products of amlodipine
por: Tiwari, Ravi N., et al.
Publicado: (2015)

Development and Validation of LC-MS/MS for Analyzing Potential Genotoxic Impurities in Pantoprazole Starting Materials
por: Chen, Yuyuan, et al.
Publicado: (2020)

Synthesis, characterization, molecular docking and biological evaluation of Schiff Base derivatives of cefpodoxime
por: Mahmood, Waqas, et al.
Publicado: (2022)

Simultaneous Determination of 15 Sulfonate Ester Impurities in Phentolamine Mesylate, Amlodipine Besylate, and Tosufloxacin Tosylate by LC-APCI-MS/MS
por: Jin, Bo, et al.
Publicado: (2019)

Synthesis, isolation, identification and characterization of new process-related impurity in isoproterenol hydrochloride by HPLC, LC/ESI-MS and NMR
por: Kumar, Neeraj, et al.
Publicado: (2017)

Identification of the Impurities in Bopu Powder(®) and Sangrovit(®) by LC-MS Combined with a Screening Method
por: Dong, Zhuang, et al.
Publicado: (2021)

Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
por: Lam, Anh K., et al.
Publicado: (2022)

Efficacy of Cefpodoxime with Clavulanic Acid in the Treatment of Recurrent Pyoderma in Dogs
por: Sudhakara Reddy, B., et al.
Publicado: (2014)

Low Level Determinations of Methyl Methanesulfonate and Ethyl Methanesulfonate Impurities in Emtricitabine Active Pharmaceutical Ingredient by LC/MS/MS Using Electrospray Ionization
por: Kakadiya, P.R., et al.
Publicado: (2011)

LC and LC–MS/MS studies for the identification and characterization of degradation products of acebutolol
por: Rakibe, Uday, et al.
Publicado: (2018)

Systematic Approach for Trace Level Quantification of 2-N-butyl-4-spirocyclopentane-2-imidazole-5-one Genotoxic Impurity in Irbesartan Using LC-MS/MS
por: Reddy, A. Vijaya Bhaskar, et al.
Publicado: (2013)

Characterization of the Oxidative Degradation Product of Darunavir by LC-MS/MS
por: Yamjala, Karthik, et al.
Publicado: (2015)

Worldwide Susceptibility Rates of Neisseria gonorrhoeae Isolates to Cefixime and Cefpodoxime: A Systematic Review and Meta-Analysis
por: Yu, Rui-xing, et al.
Publicado: (2014)

Identification of degradation impurity of TGR5 receptor agonist-ZY12201 by LC–MS technique during force degradation study
por: Sojitra, Chandrakant, et al.
Publicado: (2021)

Determination of N-nitrosodimethylamine in Ranitidine Dosage Forms by ESI-LC-MS/MS; Applications for Routine Laboratory Testing
por: Liu, Jiao, et al.
Publicado: (2021)

Metabolic Stability and Metabolite Characterization of Capilliposide B and Capilliposide C by LC–QTRAP–MS/MS
por: Cheng, Zhongzhe, et al.
Publicado: (2018)

Characterization of forced degradation products of toloxatone by LC-ESI-MS/MS
por: Skibiński, Robert, et al.
Publicado: (2018)

Development of an LC–MS/MS Assay and Toxicokinetic Characterization of Hexamethylenetetramine in Rats
por: Kim, Woojin, et al.
Publicado: (2023)

2262. Evaluation of Ceftriaxone Versus Cefazolin as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales Isolates
por: Lambert, Kaitlyn, et al.
Publicado: (2023)

Forced Degradation Behaviour of Fluphenazine Hydrochloride by LC and Characterization of its Oxidative Degradation Product by LC–MS/MS
por: Thummar, Kashyap N., et al.
Publicado: (2015)

Identification and Characterization of Hydrolytic Degradation Products of Cefditoren Pivoxil using LC and LC-MS/TOF
por: Gawande, V. T., et al.
Publicado: (2015)

Qualitative and quantitative analysis of the major constituents in traditional Chinese medicine Danmu injection using LC-ESI-MS(n) and LC-DAD
por: Zhu, Fen-Xia, et al.
Publicado: (2014)

Sapitinib: reactive intermediates and bioactivation pathways characterized by LC-MS/MS
por: Attwa, Mohamed W., et al.
Publicado: (2019)

Elemental Impurities in Pediatric Calcium Carbonate Preparations-High Throughput Quantification and Risk Assessment
por: Xiao, Chaoqiang, et al.
Publicado: (2021)

Selective separation, detection of zotepine and mass spectral characterization of degradants by LC–MS/MS/QTOF
por: Talluri, M.V.N. Kumar, et al.
Publicado: (2014)

Sustainable chromatographic quantitation of multi-antihypertensive medications: application on diverse combinations containing hydrochlorothiazide along with LC–MS/MS profiling of potential impurities: greenness and whiteness evaluation
por: Marzouk, Hoda M., et al.
Publicado: (2023)

Identification and characterization of in vivo, in vitro and reactive metabolites of vandetanib using LC–ESI–MS/MS
por: Attwa, Mohamed W., et al.
Publicado: (2018)

LC-ESI-QTOF-MS/MS Characterization of Seaweed Phenolics and Their Antioxidant Potential
por: Zhong, Biming, et al.
Publicado: (2020)

Identification, synthesis and characterization of an unknown process related impurity in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI–IT/MS, (1)H, (13)C and (1)H–(1)H COSY NMR
por: Thomas, Saji, et al.
Publicado: (2014)

Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA
por: Heleno Ferreira, Raquel Balestri, et al.
Publicado: (2019)

Identification of impurities in nafamostat mesylate using HPLC-IT-TOF/MS: A series of double-charged ions
por: Zhang, Yuxin, et al.
Publicado: (2020)

Clinical effectiveness and safety of gemifloxacin versus cefpodoxime in acute exacerbation of chronic bronchitis: A randomized, controlled trial
por: Chatterjee, S., et al.
Publicado: (2011)

In vitro assays for characterization of distinct multiple catalytic activities of thyroid peroxidase using LC-MS/MS
por: Tater, Abhishek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s38640q05cpkrl5qbqmjan6u06